alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| **CERTIFICATION OF**

**CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Ricardo Prats, the Chief Executive Officer and Chief Financial Officer of Ocean Electric Inc. (the “Company”), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(i)

the Quarterly Report on Form 10-Q/A of the Company, for the fiscal quarter ended June 30, 2012, and to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(ii)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By:

*/s/ Ricardo Prats*

 

Name:

Ricardo Prats

 

Title:

Chief Executive Officer and

 

 

Chief Financial Officer

 

 

 

 

Date:

January 3, 2012
                               |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Court of Appeals

Sixth Appellate District of Texas

J U D G M E N T

In re Mark Eugene Engle

No. 06-15-00111-CR

Original Mandamus Proceeding

Opinion delivered by Chief Justice Morriss, 

Justice Moseley and Justice Burgess

participating.

As stated in the Court’s opinion of this date, we find that Relator is not entitled to the 

relief sought. Therefore, we deny the petition.

RENDERED JULY 15, 2015

BY ORDER OF THE COURT

JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST:

Debra K. Autrey, Clerk
#### Artur Zaytsev, Respondent, v Stanacard, LLC, Appellant.

Decided September 17, 2013

Appeal, insofar as taken from that part of the Appellate Division order that affirmed Supreme Court’s order denying summary judgment, dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that the Appellate Division order does not finally determine the action within the meaning of the Constitution; appeal, insofar as taken from that part of the Appellate Division order that affirmed Supreme Court’s order granting respondent’s application to voluntarily discontinue the action without prejudice, dismissed, without costs, by the Court of Appeals, sua sponte, upon the ground that no substantial constitutional question is directly involved.

Judge Abdus-Salaam taking no part.
EXHIBIT 24

                                POWER OF ATTORNEY


         We,  the  undersigned  Directors  and  Officers  of The  Black & Decker
Corporation  (the  "Corporation"),   hereby  constitute  and  appoint  Nolan  D.
Archibald, Michael D. Mangan and Charles E. Fenton, and each of them, with power
of substitution,  our true and lawful  attorneys-in-fact with full power to sign
for us, in our names and in the capacities  indicated below,  the  Corporation's
Annual Report on Form 10-K for the year ended December 31, 2001, and any and all
amendments thereto.


/s/ NOLAN D. ARCHIBALD         Director, Chairman, President,  February 25, 2002
----------------------------   and Chief Executive Officer
Nolan D. Archibald             (Principal Executive Officer)


                               Director                        February 25, 2002
----------------------------
Norman R. Augustine


/s/ BARBARA L. BOWLES          Director                        February 25, 2002
----------------------------
Barbara L. Bowles


/s/ M. ANTHONY BURNS           Director                        February 25, 2002
----------------------------
M. Anthony Burns


/s/ MALCOLM CANDLISH           Director                        February 25, 2002
----------------------------
Malcolm Candlish


/s/ MANUEL A. FERNANDEZ        Director                        February 25, 2002
----------------------------
Manuel A. Fernandez


/s/ BENJAMIN H. GRISWOLD, IV   Director                        February 25, 2002
----------------------------
Benjamin H. Griswold, IV


/s/ ANTHONY LUISO              Director                        February 25, 2002
----------------------------
Anthony Luiso


/s/ MICHAEL D. MANGAN          Senior Vice President           February 25, 2002
----------------------------   and Chief Financial Officer
Michael D. Mangan              (Principal Financial Officer)


/s/ CHRISTINA M. MCMULLEN      Vice President and Controller   February 25, 2002
----------------------------   (Principal Accounting Officer)
Christina M. McMullen
##### 



Exhibit 12.2 ARIZONA PUBLIC SERVICE COMPANY
COMPUTATION OF EARNINGS TO FIXED CHARGES
($000s) Twelve Months Ended December 31,2004
    
    
    2003
    
    
    2002
    
    
    2001
    
    
    2000Earnings:Income from continuing
operations
    
    $
    199,627
    
    
    $
    180,937
    
    
    $
    199,343
    
    
    $
    280,688
    
    
    $
    306,594Income taxes

    
    
    120,030
    
    
    
    86,854
    
    
    
    126,805
    
    
    
    183,136
    
    
    
    195,665Fixed charges
    
    
    181,372
    
    
    
    181,793
    
    
    
    168,985
    
    
    
    166,939
    
    
    
    179,381Total earnings
    
    $
    501,029
    
    
    $
    449,584
    
    
    $
    495,133
    
    
    $
    630,763
    
    
    $
    681,640Fixed Charges:Interest charges
    
    $
    146,983
    
    
    $
    147,610
    
    
    $
    133,878
    
    
    $
    130,525
    
    
    $
    141,886Amortization of
debt discount
    
    
    4,854
    
    
    
    3,337
    
    
    
    2,888
    
    
    
    2,650
    
    
    
    2,105Estimated interest
portion
of annual rents
    
    
    29,535
    
    
    
    30,846
    
    
    
    32,219
    
    
    
    33,764
    
    
    
    35,390Total fixed charges
    
    $
    181,372
    
    
    $
    181,793
    
    
    $
    168,985
    
    
    $
    166,939
    
    
    $
    179,381Ratio of Earnings to Fixed
Charges (rounded down)
    
    
    2.76
    
    
    
    2.47
    
    
    
    2.93
    
    
    
    3.77
    
    
    
    3.79
_________________________________________ 

 

Order Michigan Supreme Court 

Lansing, Michigan 

April 13, 2007 Clifford W. Taylor,

 Chief Justice 

128158-9(55) Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

MICHELLE GOWER, Personal Robert P. Young, Jr. 

Stephen J. Markman, Representative of the Estate of Justices EDWIN GOWER, Deceased,

Plaintiff-Appellant, 

v SC: 128158, 128159 

 COA: 256824, 257967 

Ingham CC: 03-000299-NH

JAMES HARKEMA, M.D., 

CHRISTOPHER SEIP, M.D., 

BENJAMIN B. MOSHER, M.D., 

CHRISTOPHER ABOOD, M.D.,

TONIA REINCKE, PA-C, SPARROW 

HOSPITAL, GREG A. HOWELLS, M.D.,

KEITH BLUM, D.O., CHRISTINA 

MASER OHM, M.D., KEVIN KRAUSE,

M.D., GREGORY NOWINSKI, M.D.,

JULIE STEIN, M.D., and WILLIAM 

BEAUMONT HOSPITAL, ROYAL OAK, 

 Defendants-Appellees, 

and 

GEORGE ARTHUR WILLIAMS, M.D., 

and ASSOCIATED RETINAL 

CONSULTANTS, P.C., 

Defendants. 

_________________________________________/ 

On order of the Court, the motion for reconsideration of this Court’s November 2, 

2005 order is considered, and it is GRANTED. We VACATE our order dated November 

2, 2005. On reconsideration, the application for leave to appeal the January 25, 2005 and 

February 1, 2005 orders of the Court of Appeals is considered and, it appearing to this 

Court that the case of Mullins v St Joseph Mercy Hosp (Docket No. 131879) is pending 

on appeal before this Court and that the decision in that case may resolve an issue raised 

in the present application for leave to appeal, we ORDER that the application be held in 

ABEYANCE pending the decision in that case. 

d0410 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

April 13, 2007 

Clerk
97-746.

#### State v. Bass.

Stark App. No. 1995CA00347. On motion for leave to file delayed appeal. Motion granted.

Douglas and F.E. Sweeney, JJ., dissent.
#### Rocky Point Drive-In, L.P., Appellant, v Town of Brookhaven et al., Respondents.

Submitted September 9, 2013;

decided September 12, 2013

Motion by Association of Towns of the State of New York for leave to appear amicus curiae on the appeal herein granted only to the extent that the proposed brief is accepted as filed. Two copies of the brief must be served and nine copies filed within seven days.
Exhibit 99.2

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report of Baltek Corporation (the "Company") on Form 10-K for the period ended December 31, 2002 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Ronald Tassello, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|/s/RONALD TASSELLORonald Tassello
Chief Financial Officer and Treasurer
April 14, 2003 |  |  |  | 
|-------------------------------------------------------------------------------------- |  |  |  | 

23

---

QuickLinks
**Exhibit 32.1**

 

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theAnnual Report of Minuteman International, Inc. (the “Company”) on Form 10-K forthe fiscal year ending December 31, 2003 as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, Gregory J. Rau,President and Chief Executive Officer of the Company, certify, pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that based on my knowledge:

 

(1)               The Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

 

(2)               The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company. 

 

 
| /s/ Gregory J. Rau                     |   |
|----------------------------------------|--------|
| Gregory J. Rau                         |
| President and Chief  Executive Officer |
| March 12, 2004                    |

 

“The certification provided by the CAO doesnot in anyway alter the responsibilities of the CEO and CFO of MinutemanInternational, Inc. in connection with their certifications provided pursuantto Sections 302 and 906 of The Sarbanes-Oxley Act.”

 

----
# Farber's Disease

## What is Farber's disease? 

Farber's disease (also known as Farber's lipogranulomatosis) is a one of a group of rare inherited metabolic disorders called lipid storage diseases, in which excess amounts of lipids (oils, fatty acids, and related compounds) build up to harmful levels in the central nervous system, joints, and tissues. The liver, heart, and kidneys also may be affected. Farber's disease is caused by the deficiency of the enzyme called ceramidase. 

Both parents need to carry and pass on the defective gene for a child to have Farber's disease. The disease affects both males and females. In the disease's classic form, onset typically begins in early infancy but may occur later in life. Neurological symptoms may include:
              - Problems with swallowing
              - Increased lethargy and sleepiness
              - Chronic shortening of muscles or tendons around the joints
              - Moderately impaired mental ability

Other symptoms may include arthritis, swollen lymph nodes and joints, hoarseness, nodules under the skin (and sometimes in the lungs and other parts of the body), and vomiting. Some people may need a breathing tube. Most children with the classic form die by age 2, usually from lung disease.

In one of the most severe forms of the disease, an enlarged liver and spleen can be diagnosed soon after birth. Children born with this form of the disease usually die within 6 months.

Currently there is no specific treatment for Farber's disease. Corticosteroids may be prescribed to relieve pain. Bone marrow transplants may improve granulomas (small masses of inflamed tissue) on people with little or no lung or nervous system complications. Older people may have granulomas surgically reduced or removed.

file-medical

## How can I or my loved one help improve care for people with Farber's disease?

Consider participating in a clinical trial so clinicians and scientists can learn more about Farber's disease and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease. 

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them. 

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with Farber's disease at Clinicaltrials.gov.
> Where can I get more information about Farber's disease?
The following organizations offer information and other resources:

Genetics and Rare Diseases (GARD) Information Center

Hide and Seek Foundation for Lysosomal Storage Disease ResearchPhone: 844-762-7672

MedlinePlus

National Organization for Rare DiseasesPhone: 203-744-0100 or 800-999-67673

## Learn about related topics

              - Lipid Storage Diseases 

book-open
**EXHIBIT 23.2****CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**     We consent to the incorporation by reference in the RegistrationStatement (Form S-8 Nos. 333-50132 and 333-75014) pertaining tothe 1998 Incentive Compensation Plan of BKF Capital Group, Inc.of our report dated March 3, 2004 (except for the last twoparagraphs of Note 13, as to which the date is November 2,2005)with respect to the consolidated financial statements of BKFCapital Group, Inc. for the year ended December 31, 2003included in this Annual Report (Form 10-K/A) for the year endedDecember 31, 2004 and incorporation of our report datedMarch 3, 2004 (except for the last two paragraphs of Note13, as to which the date is November 2, 2005) with respectto the consolidated financial statements of BKF Capital Group,Inc. for the year ended December 31, 2003 in this AnnualReport (Form 10-K/A) for the year ended December 31, 2004./s/ ERNST & YOUNG LLPNew York, New YorkNovember 2, 2005
EXHIBIT 32.2
------------



                      SECTION 1350 CERTIFICATION



     In connection with the Quarterly Report of Landauer, Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"),
I, James M. O'Connell, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section  906 of
the Sarbanes-Oxley Act of 2002, that:

     (1)   The Report fully complies with the requirements of section
           13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2)   The information contained in the Report fairly presents, in all
           material respects, the financial condition and result of
           operations of the Company.




                                  /s/  James M. O'Connell
                                  ------------------------
                                  James M. O'Connell
                                  Chief Financial Officer


August 12, 2003




A signed original of this written statement required by Section 906 has
been provided to Landauer, Inc. and will be retained by Landauer, Inc. and
furnished to the Securities and Exchange Commission or its staff upon
request.
#### Robert Gherardi et al., Respondents, v City of New York et al., Defendants, and Harris Corporation et al., Appellants.

[852 NYS2d 126]

A contractor’s obligation under the statute is only “when constructing,” which is defined in 12 NYCRR 23-1.4 as including the same activities enumerated under Labor Law § 240 (1), and plaintiff was not “constructing, demolishing or excavating” because the ramp was not in his work area.

Even if, arguendo, defendant contractors’ argument regarding the nature of plaintiffs work may be raised at this juncture, such work, involving an extensive project for the installation of wiring on four floors of a public high school building, effected a significant physical change and was therefore an “alteration” *(see Joblon v Solow,*91 NY2d 457, 465-466 [1998]; *Weininger v Hagedorn & Co.,*91 NY2d 958, 959-960 [1998]). Although the accident occurred on an entrance ramp used for worker ingress and for bringing in materials, and not where plaintiffs work was actually being conducted, the protection of the statute extends to such area *(see Smith v McClier Corp.,*22 AD3d 369, 371 [2005]; *Whalen v City of New York,*270 AD2d 340, 342 [2000]), and it is not necessary for the offending instrumentality to have been erected for worker use. Concur—Nardelli, J.P., Williams, Sweeny and Catterson, JJ.
EXHIBIT 32.2
                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of  ONLINE  ORIGINALS,  INC.  (the
"Company")  on Form 10-QSB for the period ended May 31, 2006,  as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Gregory
Adams,  Chief Financial Officer of the Company,  certify,  pursuant to 18 U.S.C.
1350,  as adopted  pursuant  to Section 906 of the  Sarbanes-Oxley  Act of 2002,
that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.



Date:  June 26 2006


By: /s/ Gregory Adams
    --------------------------
         Gregory Adams
         Chief Financial Officer, principal financial officer and principal
         accounting officer
EXHIBIT
32.1





CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO


18
U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b)
AND 15d-14(b)


(Section 906
of the Sarbanes-Oxley Act of 2002)





In
connection with the Quarterly Report of Neuralstem, Inc. (the “Company”) on Form
10-Q for the period ending June 30, 2010, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, I.
Richard Garr, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge and belief:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of the operation of the
      Company.





/s/ I. Richard
      GarrI.
      Richard GarrChief
      Executive Officer
              Neuralstem,
      Inc




This
certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes
of Section 18 of the Securities Exchange Act of 1934, as
amended.





A signed
original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
July 9, 2015

JUDGMENT

The Fourteenth Court of Appeals

FREDY PEREZ, Appellant

NO. 14-14-00476-CR V.

THE STATE OF TEXAS, Appellee

________________________________

This cause was heard on the transcript of the record of the court below. 

Having considered the record, this Court holds that there was no error in the 

judgment. The Court orders the judgment AFFIRMED.

We further order this decision certified below for observance.
#### The People of the State of New York, Respondent, v Robert Mitchell, Appellant.

Submitted June 25, 2012;

decided August 28, 2012

Motion for assignment of counsel granted and Richard M. Greenberg, Esq., Office of the Appellate Defender, 11 Park Place, Suite 1601, New York, NY 10007 assigned as counsel to the appellant on the appeal herein.
FILED IN 4th COURT OF APPEALS SAN ANTONIO, TEXAS 7/10/2015 9:10:43 AM KEITH E. HOTTLE Clerk
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          453700
<SECURITIES>                                         0
<RECEIVABLES>                                  1953924
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               2408219
<PP&E>                                        20701187
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                24831300
<CURRENT-LIABILITIES>                          2690251
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    21856796
<TOTAL-LIABILITY-AND-EQUITY>                  24831300
<SALES>                                              0
<TOTAL-REVENUES>                                152992
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 86391
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  66601
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              66601
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     66601
<EPS-BASIC>                                       2.23
<EPS-DILUTED>                                     2.23


</TABLE>